GoodRx starts cash‑pay access to oral Ozempic for adults with type 2 diabetes

GoodRx has started offering cash-pay access to Novo Nordisk’s oral semaglutide for adults with type 2 diabetes through participating U.S. pharmacies, adding a pill option to a market dominated by injectable GLP-1 drugs. The company announced the move on May 1, saying eligible self-pay patients can obtain the treatment for as low as $149 per month. (investors.goodrx.com) Pharmaceutical Commerce reported the rollout as part of a broader push to expand non-insurance access to GLP-1 medicines amid continued pricing pressure and uneven coverage. The new listing matters because GoodRx is positioning the product as a transparent cash-price option rather than an insurance benefit. GoodRx said the oral offering is available through its nationwide pharmacy network, and its main site says that network spans more than 70,000 U.S. pharmacies. (investors.goodrx.com) The company described the addition as an expansion of its Ozempic treatment portfolio for people with type 2 diabetes. ### Which drug is GoodRx actually adding? GoodRx said the new option is Novo Nordisk’s “Ozempic pill,” which it identified as oral semaglutide for adults with type 2 diabetes. Pharmaceutical Commerce used the same description in its May 1 report on the program. GoodRx’s broader GLP-1 materials also say semaglutide is sold under the diabetes brands Ozempic and Rybelsus, while most GLP-1 products are injections and one option is oral. (investors.goodrx.com) The terminology reflects GoodRx’s marketing language rather than a regulatory label in the materials reviewed. In its release, GoodRx repeatedly referred to the product as the “Ozempic pill” and “oral semaglutide.” (investors.goodrx.com) ### What does the cash-pay offer cost? GoodRx said eligible self-pay patients can fill the oral medicine at transparent monthly prices of $149, $199 or $299, depending on dose. Pharmaceutical Commerce reported the same three price points and said the program would run through GoodRx-participating pharmacies nationwide. Those prices sit below the ongoing self-pay price GoodRx currently advertises for many injectable Ozempic fills. (investors.goodrx.com) A GoodRx savings page says new users of injectable Ozempic can pay an introductory $199 per month for the first two fills for certain doses, with most ongoing fills priced at $349 per month depending on dose. ### Why is GoodRx emphasizing self-pay patients? (investors.goodrx.com) Pharmaceutical Commerce said claims-based data link higher out-of-pocket GLP-1 costs to lower initiation rates in type 2 diabetes. The publication said that makes affordability a determinant of whether patients start treatment in real-world use. GoodRx has been building out that self-pay channel across GLP-1 products. (investors.goodrx.com) In April, the company said it was expanding self-pay access to Eli Lilly’s oral GLP-1 Foundayo and Zepbound KwikPen through the same pharmacy network. GoodRx has also published consumer guidance saying expanded direct-to-consumer and cash-pay programs are among the GLP-1 trends to watch in 2026. (goodrx.com) ### Why does the pill format matter here? Pharmaceutical Commerce said oral administration offers a non-injectable semaglutide option that may address patient and clinician concerns about injections. The publication said that could increase GLP-1 prescribing in primary care. (pharmaceuticalcommerce.com) GoodRx’s own GLP-1 guide says most drugs in the class are injections, with one oral option available. That distinction gives the company a separate access pitch as it tries to reach patients who want brand-name semaglutide without starting with a shot. ### Where can patients find the next step? GoodRx said eligible patients can access the oral treatment through its participating pharmacy network and listed the offer in a May 1 investor release. (pharmaceuticalcommerce.com) The company’s pharmacy platform says consumers can compare prices and coupons across more than 70,000 U.S. pharmacies, which is where the cash-pay option is being routed. (investors.goodrx.com) (goodrx.com) (pharmaceuticalcommerce.com)